Biomarker ID | 1555 |
PMID | 25252191 |
Year | 2014 |
Biomarker | miR-141 |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in Recurrent Cases (Recurrent Median: 0.39; Control Median: 0.81) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathway include: regulation of RNA metabolic process; Gene expression (Transcription); RNA Polymerase II Transcription; nuclear chromosome; DNA-binding transcription factor activity, RNA polymerase II-specific |
Experiment | Recurrence Vs No Recurrence |
Type of Biomarker | Prognostic |
Cohort | 59 cases with Recurrence and 59 controls were used for the study |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.0001 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |